Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Arancio

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biological Psychiatry|April 15, 1995
Menstrual cycle-related sensitivity to 35% CO2 in panic patientsG Perna, F Brambilla, C Arancio, et al.
Psychiatry Research|January 15, 1997
Panic attacks: a twin studyG Perna, D Caldirola, C Arancio, et al.
Psychiatry Research|January 30, 1999
Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorderF Brambilla, L Bellodi, G Perna, et al.
Psychoneuroendocrinology|March 22, 2001
Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approachF Brambilla, L Bellodi, C Arancio, et al.
The American Journal of Psychiatry|January 1, 1995
Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challengesG Perna, A Bertani, C Arancio, et al.
Psychiatry Research|June 16, 1997
The 35% CO2 challenge test in patients with social phobiaD Caldirola, G Perna, C Arancio, et al.
The American Journal of Psychiatry|April 1, 1995
Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorderG Perna, S Cocchi, A Bertani, et al.
Journal of Clinical Psychopharmacology|December 1, 1994
Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled studyG Perna, S Cocchi, A Bertani, et al.
Journal of Clinical Psychopharmacology|April 1, 1997
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled studyA Bertani, G Perna, C Arancio, et al.
Biological Psychiatry|November 14, 1997
Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulationF Brambilla, L Bellodi, G Perna, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biological Psychiatry|April 15, 1995
Menstrual cycle-related sensitivity to 35% CO2 in panic patientsG Perna, F Brambilla, C Arancio, et al.
Psychiatry Research|January 15, 1997
Panic attacks: a twin studyG Perna, D Caldirola, C Arancio, et al.
Psychiatry Research|January 30, 1999
Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorderF Brambilla, L Bellodi, G Perna, et al.
Psychoneuroendocrinology|March 22, 2001
Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approachF Brambilla, L Bellodi, C Arancio, et al.
The American Journal of Psychiatry|January 1, 1995
Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challengesG Perna, A Bertani, C Arancio, et al.
Psychiatry Research|June 16, 1997
The 35% CO2 challenge test in patients with social phobiaD Caldirola, G Perna, C Arancio, et al.
The American Journal of Psychiatry|April 1, 1995
Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorderG Perna, S Cocchi, A Bertani, et al.
Journal of Clinical Psychopharmacology|December 1, 1994
Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled studyG Perna, S Cocchi, A Bertani, et al.
Journal of Clinical Psychopharmacology|April 1, 1997
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled studyA Bertani, G Perna, C Arancio, et al.
Biological Psychiatry|November 14, 1997
Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulationF Brambilla, L Bellodi, G Perna, et al.
Pageof 2